N,N'-二乙酰-L-胱氨酸 ,AR,97%
L-Cystine,N,N'-diacetyl-
| 別名: | N,N'-二乙酰-L-胱氨酸 ,N'-二乙酰-L-胱氨酸;N,N'-二乙?；?L-胱氨酸;乙酰半胱氨酸EP雜質(zhì)C;雙乙酰化-L-胱氨酸;S-[2-(乙酰氨基Chemicalbook)乙基]羧酸;N,N'-二乙酰-L-胱氨酸;乙酰半胱氨酸雜質(zhì)C(EP);乙酰半胱氨酸相關(guān)化合物C(USP);乙酰半胱氨酸雜質(zhì)10 | ||
|---|---|---|---|
| Cas號(hào): | 5545-17-5 | 物化性質(zhì): | |
| 分子式: | C10H16N2O6S2 | 熔點(diǎn): | |
| 分子量: | 324.37 | 沸點(diǎn): | |
| EINECS編號(hào): | 密度: | ||
| MDL號(hào): | 儲(chǔ)存條件: | ||
中文名稱(chēng)：N,N'-二乙酰-L-胱氨酸
CAS號(hào)：5545-17-5
中文別名：N,N'-二乙酰-L-胱氨酸 ,N'-二乙酰-L-胱氨酸;N,N'-二乙?；?L-胱氨酸;乙酰半胱氨酸EP雜質(zhì)C;雙乙?；?L-胱氨酸;S-[2-(乙酰氨基Chemicalbook)乙基]羧酸;N,N'-二乙酰-L-胱氨酸;乙酰半胱氨酸雜質(zhì)C(EP);乙酰半胱氨酸相關(guān)化合物C(USP);乙酰半胱氨酸雜質(zhì)10
英文名稱(chēng)：L-Cystine,N,N'-diacetyl-
分子式：C10H16N2O6S2
分子量：324.37
顏色：White to Light Beige
生物活性：N,N'-diacetyl-L-cystine(DiNAC)是一種具有免疫調(diào)節(jié)特性的N-乙?；腚装彼岬亩蚨垠w。N,N'-diacetyl-L-cystine是嚙齒類(lèi)動(dòng)物中接觸敏感/遲發(fā)型超敏反應(yīng)的有效口服活性調(diào)節(jié)劑。N,N'-diacetyl-L-cystine在高脂血癥兔(WHHL)中也具有抗動(dòng)脈粥樣硬化的作用。
靶點(diǎn)：Immunomodulator
體內(nèi)研究：N,N'-Diacetyl-L-cystine(DiNAC;0-973.11μg/kg;oraladministration;daily;for12weeks;WHHLrabbits)treatmentreducesby50%tChemicalbookhoracicaortaatherosclerosis,withoutaffectingplasmalipidlevels.AnimalModel:Maleheritablehyperlipidemicrabbit(WHHL)rabbits(10-22weeks)Dosage:0μg/kg,9.73μg/kg,or973.11μg/kgAdministration:Oraladministration;daily;for12weeksResult:Reducedby50%thoracicaortaatherosclerosis,withoutaffectingplasmalipidlevels.
CAS號(hào)：5545-17-5
中文別名：N,N'-二乙酰-L-胱氨酸 ,N'-二乙酰-L-胱氨酸;N,N'-二乙?；?L-胱氨酸;乙酰半胱氨酸EP雜質(zhì)C;雙乙?；?L-胱氨酸;S-[2-(乙酰氨基Chemicalbook)乙基]羧酸;N,N'-二乙酰-L-胱氨酸;乙酰半胱氨酸雜質(zhì)C(EP);乙酰半胱氨酸相關(guān)化合物C(USP);乙酰半胱氨酸雜質(zhì)10
英文名稱(chēng)：L-Cystine,N,N'-diacetyl-
分子式：C10H16N2O6S2
分子量：324.37
顏色：White to Light Beige
生物活性：N,N'-diacetyl-L-cystine(DiNAC)是一種具有免疫調(diào)節(jié)特性的N-乙?；腚装彼岬亩蚨垠w。N,N'-diacetyl-L-cystine是嚙齒類(lèi)動(dòng)物中接觸敏感/遲發(fā)型超敏反應(yīng)的有效口服活性調(diào)節(jié)劑。N,N'-diacetyl-L-cystine在高脂血癥兔(WHHL)中也具有抗動(dòng)脈粥樣硬化的作用。
靶點(diǎn)：Immunomodulator
體內(nèi)研究：N,N'-Diacetyl-L-cystine(DiNAC;0-973.11μg/kg;oraladministration;daily;for12weeks;WHHLrabbits)treatmentreducesby50%tChemicalbookhoracicaortaatherosclerosis,withoutaffectingplasmalipidlevels.AnimalModel:Maleheritablehyperlipidemicrabbit(WHHL)rabbits(10-22weeks)Dosage:0μg/kg,9.73μg/kg,or973.11μg/kgAdministration:Oraladministration;daily;for12weeksResult:Reducedby50%thoracicaortaatherosclerosis,withoutaffectingplasmalipidlevels.
搜索質(zhì)檢報(bào)告(COA)
搜索MSDS
N,N'-二乙酰-L-胱氨酸
L-Cystine,N,N'-diacetyl-;(Ac-Cys-OH)?;(Ac-Cys-OH)?;(Ac-L-Cys-OH)2;N,N’-DIACETYL-L-CYSTINE;N,N'-diacetyl-L-Cystine;ACETYL-L-CYSTINE;diacetylcysteine;DiNAC;L-Cystine,N,N'-diacetyl;N,N`-Diacetyl-L-cystine;N,N'-diacetyl-cystine;N,N''-Diacetyl-L-cysteine;N-ACETYL CYSTINE;N-acetyl-L-cystine;N,N′-Diacetyl-L-cystine;NSC 203780
